Company intelligence / Profile preview

iPremom

Ownership: Private
Development stage: Clinical

Overview

iPremom is developing innovative molecular blood tests to enable the early detection and prediction of pregnancy complications, particularly preeclampsia. The company leverages expertise in obstetrics, biotechnology, and computational biology to translate scientific knowledge into practical diagnostic solutions. Clinical results are not detailed publicly; the focus remains on development and validation.

Therapeutic areas: Women's Health
Modalities: Molecular diagnostics
Industry: Molecular Diagnostics

Beyond the preview

Go deeper on iPremom.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on iPremom.

Explore the full profile